GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Xinhua Pharmaceutical Co Ltd (SZSE:000756) » Definitions » Market Cap
中文

Shandong Xinhua Pharmaceutical Co (SZSE:000756) Market Cap : ¥8,637 Mil (As of Apr. 24, 2024)


View and export this data going back to 1997. Start your Free Trial

What is Shandong Xinhua Pharmaceutical Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Shandong Xinhua Pharmaceutical Co's share price for the quarter that ended in Dec. 2023 was ¥20.38. Shandong Xinhua Pharmaceutical Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 675 Mil. Therefore, Shandong Xinhua Pharmaceutical Co's market cap for the quarter that ended in Dec. 2023 was ¥13,750 Mil.

Shandong Xinhua Pharmaceutical Co's quarterly market cap declined from Jun. 2023 (¥14,560 Mil) to Sep. 2023 (¥13,581 Mil) but then increased from Sep. 2023 (¥13,581 Mil) to Dec. 2023 (¥13,750 Mil).

Shandong Xinhua Pharmaceutical Co's annual market cap increased from Dec. 2021 (¥7,020 Mil) to Dec. 2022 (¥20,156 Mil) but then declined from Dec. 2022 (¥20,156 Mil) to Dec. 2023 (¥13,750 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Shandong Xinhua Pharmaceutical Co's Enterprise Value for Today is ¥8,924 Mil.


Shandong Xinhua Pharmaceutical Co Market Cap Historical Data

The historical data trend for Shandong Xinhua Pharmaceutical Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Xinhua Pharmaceutical Co Market Cap Chart

Shandong Xinhua Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,676.38 5,833.04 7,020.24 20,155.77 13,750.04

Shandong Xinhua Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20,155.77 16,469.82 14,559.66 13,581.37 13,750.04

Competitive Comparison of Shandong Xinhua Pharmaceutical Co's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Shandong Xinhua Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Xinhua Pharmaceutical Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shandong Xinhua Pharmaceutical Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Shandong Xinhua Pharmaceutical Co's Market Cap falls into.



Shandong Xinhua Pharmaceutical Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Shandong Xinhua Pharmaceutical Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=¥20.38*674.683
=¥13,750

Shandong Xinhua Pharmaceutical Co's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=¥20.38*674.683
=¥13,750

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shandong Xinhua Pharmaceutical Co  (SZSE:000756) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Shandong Xinhua Pharmaceutical Co Market Cap Related Terms

Thank you for viewing the detailed overview of Shandong Xinhua Pharmaceutical Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Xinhua Pharmaceutical Co (SZSE:000756) Business Description

Traded in Other Exchanges
Address
No. 1 Lutai Avenue, Hi-tech Industry Development Zone, Zibo City, Shandong, CHN, 255086
Shandong Xinhua Pharmaceutical Co Ltd is a pharmaceutical products manufacturer based in China. It operates the business through the following segments: Chemical bulk drugs, Preparations, Chemical intermediates, and other products. The company provides chemical bulk drug products, including metamizole sodium, caffeine, aminopyrine, aspirin, hydrocortisone, pipemidic acid, ibuprofen, and L-dopa, it also dispenses formulation products such as compound liquorice tablets and nimodipine tablets. Its products address disorders related to the central nervous system and the cerebrovascular system with the help of antipyretics and analgesics.

Shandong Xinhua Pharmaceutical Co (SZSE:000756) Headlines

No Headlines